Eraxis

Eraxis (anidulafungin) is approved for use in adults and children for the treatment of infections in the stomach and esophagus caused by a fungus called Candida. Additionally, the Infectious Diseases Society of America (IDSA) recommends Eraxis (anidulafungin) for the treatment of Candida infections in certain other parts of the body too. The medication isn't FDA approved for this purpose, but professional organizations like the IDSA have recommended it based on strong clinical evidence. Eraxis (anidulafungin) is mostly used as part of empiric therapy, which means it's used to fight possible fungal infections when it's not known which specific fungus is causing an infection. It might also be used for people who have infections that are difficult to treat with certain other antifungals (e.g., fluconazole (Diflucan) and other similar antifungals).

Eraxis (anidulafungin) is an antifungal medication. It kills fungi by preventing their ability to make a protective covering around themselves.

Eraxis (anidulafungin) is typically given as an injection through the veins (intravenously or IV) in the hospital. Each infusion time takes about 45 minutes to 3 hours, depending on your dose.

The typical dose for adults is 100 mg or 200 mg injected through your vein (intravenously or IV) once for the first dose. After that, you'll receive 50 mg or 100 mg IV once daily. The dose for children 1 month of age and older is based on their body weight. Similar to adults, children will receive a higher dose to start, and then a lower dose for the rest of their treatment. The typical length of treatment with Eraxis (anidulafungin) is up to 2 weeks.